|
Study ID | Sample | Diagnosis standard | Intervention | Control | Course (week) | Followup (month) | Outcome measure |
|
Du et al. [8] | 120 | CCMD-3 | xiaoyao pill plus fluoxetine | amitriptyline paroxetine | 6–8 | | HAMD and TESS score, side effect |
Huang and Gan [9] | 69 | ICD-10 | Shugan jieyu formula | amitriptyline | 6 | | clinical effect, side effect |
Huo et al. [10] | 72 | CCMD-3 | danzhi xiaoyao decoction plus fluoxetine | fluoxetine | 6 | | clinical effect, HAMD, HAMA and CJI score, side effect |
J. Li et al. [11] | 60 | CCMD-3 | xiaoyao pill plus imipramine | imipramine | 8 | | clinical effect, HAMD score, side effect |
Y. J. Li et al. [12] | 66 | CCMD-3, ICD-10 | danzhixiaoyao powder | maprotiline | 6 | | HAMD score, 5-HT, NE, EDNF, CORT, IL-6, IL-1β |
H. Li et al. [13] | 80 | Unclear | xiaoyao powder plus fluoxetine | fluoxetine | 6 | 12 | clinical effect, HAMD, SDS score, side effect |
Liu and Chen 2007 [14] | 78 | “practice of internal medicine”-3 | danzhixiaoyao powder plus amitriptyline | amitriptyline | 8 | | clinical effect, HAMD score |
Luo et al. 2006 [15] | 66 | CCMD-3, ICD-10 | danzhixiaoyao powder | maprotiline | 6 | | symptoms, clinical effect, HAMD, SDS, SAS and Asberg score, side effect |
Ma 2007 [16] | 60 | CCMD-3 | xiaoyao pill plus citalopram | citalopram | 8 | 12 | clinical effect, HAMD and Tess score, side effect |
C. Y. Wang et al. 2004 [17] | 200 | CCMD-2-R | guipi xiaoyao pill | venlafaxine | 4 | | clinical effect, SDS score, side effect |
R. C. Wang 2008 [18] | 60 | CCMD-3 | modifiedxiaoyao powder | amitriptyline | 6 | | clinical effect, HAMD score, side effect |
T. Y. Wang 2001 [19] | 61 | CCMD-2-R ICD-10 | danzhixiaoyao decoction | fluoxetine | 6 | | clinical effect, SDS score, side effect |
W. A. Wang et al. 2005 [20] | 68 | CCMD-3 | xiaoyao pill plus doxepin | fluoxetine | 6 | | clinical effect, HAMD and HAMA score, side effect |
Y. Wang and Liu [21] | 60 | CCMD-3 | danzhixiaoyao powder plus fluoxetine | fluoxetine | 8 | | clinical effect, HAMD and CGI-SI score, side effect |
Wei et al. 1999 [22] | 60 | CCMD-2-R | xiaoyao powder plus amitriptyline | amitriptyline | 4 | | clinical effect |
Xian et al. [23] | 60 | CCMD-3 | xiaoyao powder | fluoxetine | 6 | | symptoms, clinical effect, HAMD score |
Xiao [24] | 66 | CCMD-3 | danzhixiaoyao powder plus clomipramine | clomipramine | 8 | | clinical effect |
Yang and Xie [25] | 58 | CCMD-2 | xiaoyao powder plus amitriptyline or clomipramine | amitriptyline or clomipramine | 12 | | clinical effect, TESS score, side effect |
Yang et al. [26] | 64 | CCMD-3 | modified xiaoyao pill plus amitriptyline | fluoxetine | 12 | 3 | clinical effect, HAMD score, side effect |
Zhai et al. [7] | 24 | CCMD-2-R | xiaoyao powder plus doxepin | doxepin | 8 | | clinical effect, HAMD and TESS score, side effect |
Zhang et al. [27] | 59 | CCMD-3 | xiaoyao pill plus fluoxetine | fluoxetine | 6 | | clinical effect, HAMD and TESS score, side effect |
Zhang [28] | 50 | CCMD-3 | xiaoyao pill plus fluoxetine | fluoxetine | 6 | | HAMD score, side effect |
Zhao and Jiang [29] | 66 | CCMD-3 | modified xiaoyao powder plus amitriptyline | amitriptyline | 12 | | symptoms, clinical effect, HAMD score, side effect |
Zhou and Li [30] | 90 | CCMD-3 | xiaoyao powder | fluoxetine | 8 | | symptoms, clinical effect, HAMD and SDS score, side effect |
Zhu [31] | 60 | CCMD-2 | xiaoyao pill plus venlafaxine | venlafaxine | 10 | | HAMD score, side effect |
Zhu and Li [32] | 60 | CCMD-2 | xiaoyao powder plus amitriptyline | amitriptyline | 8 | | clinical effect, side effect |
|